CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-09). The draft was written by AI, all 3 cited sources were opened and checked for existence, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 156 · Search date 2026-07-09 · Methodology v0.6

Sulforaphane/broccoli sprout extract,
does it really help with Antioxidant, detoxification, and anticancer?

30-Second Summary
C
Evidence Grade C · 52 · Safety caution
There is human biomarker evidence, but it is not anticancer clinical evidence
What the
research shows
Sulforaphane has human RCT signals of "detoxification/defense response," such as benzene and acrolein excretion, aflatoxin-related biomarkers, and Nrf2-related markers. However, evidence for clinical endpoints showing reduced cancer incidence or mortality, or enhanced anticancer treatment effect, is insufficient, so anticancer claims should be read as surrogate-marker-level claims.
What the
ads claim
Advertisements broadly claim 'Nrf2 activation,' 'detoxification,' 'anticancer,' 'liver detox,' 'cell protection,' and 'inflammation suppression.' The strongest human evidence is biomarker change, not reduced clinical disease.
*

Useful facts when choosing a product

  • Actual exposure from broccoli sprout products varies greatly depending on glucoraphanin, sulforaphane, and myrosinase activity.
  • Heating, processing methods, and gut microbiota affect sulforaphane formation.
  • During anticancer treatment, concomitant supplement use should be discussed with the treating clinician.
  • Food-level intake is generally safe, but long-term safety of high-concentration supplements is limited.
Gap Measurement · Verdict 156 · C 52
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The Kensler 2005 Qidong study evaluated the effect of a glucosinolate-rich broccoli sprout beverage on carcinogen-related biomarkers such as aflatoxin-DNA adducts and phenanthrene tetraol. The Egner 2014 Cancer Prevention Research RCT provided a broccoli sprout beverage to 291 adults in Qidong, China for 12 weeks and reported a 61% increase in benzene metabolite excretion rate and a 23% increase in acrolein metabolite excretion rate. Some clinical trials exist in prostate cancer, pancreatic cancer, and other settings, but they are small or centered on PSA, gene expression, or survival secondary analyses, and are insufficient for conclusions on cancer prevention or treatment.

02

Why this is classified as C (52)

Because of the size of the human RCTs and biological consistency, it can be viewed as the upper end of C. However, under boundary rules, surrogate markers alone cannot raise anticancer or detoxification clinical effects to B, so the score is 52.

Counterpoint. The study signal for lowering environmental carcinogen exposure biomarkers is noteworthy. This judgment does not extend that signal to cancer prevention or treatment effects.

Rejudgment record. Draft — Human biomarker RCTs exist, but cancer and detoxification clinical endpoints are absent

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Egner PA et al. 2014Randomized clinical trial291U.S. NIH and other public research fundingBenzene and acrolein metabolite excretionBenzene excretion rate increased by 61%, and acrolein excretion rate by 23%.Key
Kensler TW et al. 2005Randomized clinical trial200Primarily public research fundingAflatoxin-DNA adduct and phenanthrene tetraolEvaluated changes in carcinogen-related biomarkers.Key
Study 3Prostate-cancer-related dietary intervention RCTPublic/mixedPSA, gene expression, and progression markersSome biological signals were present, but conclusions on cancer clinical endpoints were limited.Supportive
§

Receipt — 3 References

Every cited source was opened and checked against the live page on 2026-07-09.

Egner PA, Chen JG, Zarth AT, et al. Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. Cancer Prev Res. 2014;7(8):813-823. PMID: 24913818. DOI: 10.1158/1940-6207.CAPR-14-0103.
checked
Kensler TW, Chen JG, Egner PA, et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong. Cancer Epidemiol Biomarkers Prev. 2005;14(11):2605-2613. PMID: 16030186.
checked
Traka MH, et al. Broccoli-rich diets and prostate cancer molecular/clinical markers: randomized dietary intervention studies. Am J Clin Nutr/related publications. 2019.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-09 · Corrections: none

Cite this verdict

Sulforaphane/broccoli sprout extract x antioxidant, detoxification, and anticancer Evidence Grade C card
[Chamgap] Sulforaphane/broccoli sprout extract x antioxidant, detoxification, and anticancer — Evidence Grade C·52. 3 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/antioxidant-aging/sulforaphane-antioxidant-detox-cancer/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.